On the contrary, in HT-sensitive cancer cells, both murine and human CAFs induced “de novo” HT resistance through the induction of the Notch-mediated breast cancer stem cell-like phenotype that expressed low levels of ER [78]. The gene discussed is ESR1; the disease is breast carcinoma.